IP Library Granted Patent US 12,426,940
Granted Patent B2
US 12,426,940 · App. 17/908,935 · Granted Sep 30, 2025

Electrode assemblies with non-contact temperature sensing for thermal measurements

Inventors: Kevin John Snyder (Redmond, WA); Frederick Jay Bennett (Bellevue, WA); Rolf T. Boone (Kirkland, WA); Craig Collins (Woodinville, WA)
Assignee: Solta Medical Ireland Limited
A61B18/14A61B2018/00791A61B2018/147
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,426,940
App. No.
17/908,935
Granted
Sep 30, 2025
Kind
B2
Abstract

Devices for directing electromagnetic energy to tissue during cosmetic procedures, as well as methods of treatment and methods of device manufacture. An electrode assembly includes a housing, an electrode, and a thermal sensor arranged inside the housing. The electrode, which includes an aperture, is configured to deliver electrical energy to a targeted area of a patient. The thermal sensor is positioned relative to the aperture of the electrode to provide a field of view through the aperture to a surface of the targeted area. The thermal sensor is configured to generate sensor data indicative of a temperature at the surface of the targeted area, and to thereby provide non-contact temperature sensing.

Claims (40)

1. An electrode assembly comprising:

a first housing;

an electrode inside the first housing, the electrode configured to deliver electrical energy to a targeted area of a patient, and the electrode including a first aperture;

a first flexible circuit that includes the electrode;

a second flexible circuit; and

a first thermal sensor inside the first housing, the first thermal sensor mounted to the second flexible circuit, the first thermal sensor positioned relative to the first aperture of the electrode to provide a first field of view through the first aperture to a surface of the targeted area, and the first thermal sensor configured to generate first sensor data indicative of a temperature at the surface of the targeted area.

2. The electrode assembly of claim 1 wherein the first thermal sensor is an infrared temperature sensor.

3. The electrode assembly of claim 1 further comprising:

a window positioned on the first housing between the first thermal sensor and the surface of the targeted area.

4. The electrode assembly of claim 3 wherein the window is a long-pass optical filter configured to pass optical energy having wavelengths within an infrared region of the electromagnetic spectrum.

5. The electrode assembly of claim 3 wherein the window is located within the first aperture.

6. The electrode assembly of claim 3 wherein the window comprises silicon, zinc selenide, germanium, zinc sulfide, calcium fluoride, or a combination thereof.

7. The electrode assembly of claim 1 wherein the electrode includes a second aperture, and further comprising:

a second thermal sensor inside the first housing, the second thermal sensor positioned relative to the second aperture in the electrode to provide a second field of view through the second aperture to the surface of the targeted area, and the second thermal sensor configured to generate second sensor data indicative of the temperature at the surface of the targeted area.

8. The electrode assembly of claim 1 further comprising:

a second housing configured to support the first thermal sensor and to position the first thermal sensor within the first housing relative to the first aperture.

9. The electrode assembly of claim 8 wherein the second housing comprises a thermally-resistive material configured to thermally isolate the first thermal sensor from a space between the first housing and the second housing.

10. The electrode assembly of claim 8 wherein the second housing comprises a shielding material configured to absorb electromagnetic radiation associated with the electrical energy delivered from the electrode to the targeted area.

11. The electrode assembly of claim 1 wherein the first flexible circuit includes a flexible substrate, and the first aperture further extends through the flexible substrate.

12. The electrode assembly of claim 11 further comprising:

a window positioned inside the first housing between the first thermal sensor and the surface of the targeted area.

13. The electrode assembly of claim 12 wherein the window comprises silicon, zinc selenide, germanium, zinc sulfide, calcium fluoride, or a combination thereof.

14. The electrode assembly of claim 12 wherein the window is a long-pass optical filter configured to pass optical energy having wavelengths within an infrared region of the electromagnetic spectrum.

15. The electrode assembly of claim 12 wherein the window is located within the first aperture.

16. The electrode assembly of claim 1 further comprising:

a window positioned inside the first housing between the first thermal sensor and the surface of the targeted area.

17. An apparatus comprising:

an electrode assembly including a housing, an electrode inside the housing, a first flexible circuit that includes the electrode, a second flexible circuit, and a thermal sensor inside the housing, the electrode configured to deliver electrical energy to a targeted area of a patient, the thermal sensor mounted to the second flexible circuit, the electrode including an aperture, and the thermal sensor positioned relative to the aperture to provide a field of view through the aperture of the electrode to a surface of the targeted area, and the thermal sensor configured to generate sensor data indicative of a temperature at the surface of the targeted area;

a handpiece configured to removably receive the electrode assembly;

a generator coupled to the electrode assembly, the generator configured to generate the electrical energy; and

a controller coupled to the generator, the electrode, and the thermal sensor, the controller configured to regulate the electrical energy generated by the generator based on the sensor data.

18. A method comprising:

attaching a non-contact thermal sensor to a first flexible printed circuit;

forming an aperture extending through an electrode of a second flexible printed circuit; and

assembling the first flexible printed circuit and the second flexible printed circuit inside of a housing,

wherein the non-contact thermal sensor is positioned inside the housing with a field of view through the aperture in the electrode.

19. The method of claim 18 further comprising:

positioning a window inside the aperture.

20. The method of claim 18 further comprising:

surrounding the non-contact thermal sensor with a first material configured to provide thermal isolation or a second material configured to absorb electromagnetic radiation.

Assignments (8)
U.S. PATENT SECURITY AGREEMENT Recorded Nov 25, 2025
From: SOLTA MEDICAL IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0394 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 9, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 063942/0001 →
CONFIRMATORY PATENTS ASSIGNMENT Recorded Jan 11, 2023
From: BAUSCH HEALTH IRELAND LIMITED
To: SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 062352/0396 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Continuity (2)
Provisional Application 62985458 · Mar 5, 2020
Related Publication 20230089551A1 · Mar 23, 2023
References Cited (24)
US 5522662A · Shiokawa · 1996 [cited by examiner]
US 7473251B2 · Knowlton · 2009 [cited by examiner]
US 9161802B2 · Przybyszewski · 2015 [cited by examiner]
US 11273316B2 · Collins · 2022 [cited by examiner]
US 20040111087A1 · Stern et al. · 2004 [cited by applicant]
US 20070198004A1 · Altshuler et al. · 2007 [cited by applicant]
US 20080200861A1 · Shalev · 2008 [cited by examiner]
US 20080200969A1 · Weber · 2008 [cited by examiner]
US 20090149930A1 · Schenck · 2009 [cited by applicant]
US 20100179531A1 · Nebrigic et al. · 2010 [cited by applicant]
US 20110015687A1 · Nebrigic · 2011 [cited by examiner]
US 20130278226A1 · Cong et al. · 2013 [cited by applicant]
US 20140188099A1 · Przybyszewski · 2014 [cited by applicant]
US 20140266235A1 · Mathur · 2014 [cited by applicant]
US 20170007146A1 · Schulhauser et al. · 2017 [cited by applicant]
CN 102348425A · 2012 [cited by applicant]
CN 110639128A1 · 2020 [cited by applicant]
TW M434931U · 2012 [cited by applicant]
WO 2007106339A2 · 2007 [cited by applicant]
WO 2016070134A1 · 2016 [cited by applicant]
Taiwan Intellectual Property Office; Examination Report issued in Taiwanese Patent Application No. 110107300 on Nov. 6, 2024; 23 pages. [cited by applicant]
European Patent Office, International Search Report and Written Opinion issued in International Patent Application No. PCT/EP2021/055472, 11 pages (Jun. 6, 2021). [cited by applicant]
Taiwan Intellectual Property Office; Examination Report issued in Taiwanese Patent Application No. 110107300 on May 10, 2024; 19 pages. [cited by applicant]
Taiwan Intellectual Property Office; Examination Report issued in Taiwanese Patent Application No. 110107300 on Jul. 31, 2024; 22 pages. [cited by applicant]